Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids MA Frias, S Mukhopadhyay, E Lehman, A Walasek, M Utter, D Menon, ... Journal of Biological Chemistry 295 (1), 263-274, 2020 | 28 | 2020 |
Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells O Le Gendre, A Sookdeo, SA Duliepre, M Utter, M Frias, DA Foster Molecular Cancer Research 11 (5), 474-481, 2013 | 25 | 2013 |
Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes M Utter, S Chakraborty, L Goren, L Feuser, YS Zhu, DA Foster Cancer letters 423, 28-35, 2018 | 14 | 2018 |
Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin S Chakraborty, MB Utter, MA Frias, DA Foster Cancer letters 522, 164-170, 2021 | 9 | 2021 |
RB and CDKN2A cause Rapamycin resistance in cancer cells S Chakraborty, M Utter, D Foster The FASEB Journal 33 (S1), lb283-lb283, 2019 | | 2019 |
Mechanisms for Survival and Drug Resistance in Cancer Cells M Utter City University of New York, 2018 | | 2018 |